← back to search

Vasilisa A. Rudneva

Memorial Sloan Kettering Cancer Center · US
Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research interests include Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, RNA modifications and cancer, and Glioma Diagnosis and Treatment.
h-index
32
citations
17,662
works
88
NIH funding
primary concept
email

Recent publications

Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma
Nature Communications 2019cited by 110position: middledoi
Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
Nature Communications 2019cited by 84position: middledoi
Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children’s Oncology Group (ACNS1221)
Journal of Clinical Oncology 2019cited by 73position: middledoi
PATH-54. MULTI-DIMENSIONAL MOLECULAR CHARACTERIZATION OF PATIENT-MATCHED MEDULLOBLASTOMA AT DIAGNOSIS AND RELAPSE
Neuro-Oncology 2019cited by 0position: middledoi
The landscape of genomic alterations across childhood cancers
Nature 2018cited by 1,589position: middledoi
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
The Lancet Oncology 2018cited by 230position: middledoi
Author Correction: The landscape of genomic alterations across childhood cancers
Nature 2018cited by 28position: middledoi
MBRS-34. MOLECULAR CHARACTERIZATION OF RECURRENT MEDULLOBLASTOMA REVEALS AN UNEXPECTEDLY HIGH INCIDENCE OF SECONDARY MALIGNANCY
Neuro-Oncology 2018cited by 1position: middledoi
MBCL-44. THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (iMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)
Neuro-Oncology 2018cited by 0position: middledoi
MBCL-21. EARLY CHILDHOOD MEDULLOBLASTOMA: SUBGROUP-SPECIFIC SURVIVAL IN PATIENTS TREATED WITH SYSTEMIC CHEMOTHERAPY AND INTRAVENTRICULAR MTX TO AVOID CRANIOSPINAL RADIOTHERAPY
Neuro-Oncology 2018cited by 0position: middledoi
The whole-genome landscape of medulloblastoma subtypes
Nature 2017cited by 1,179position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Paul A. Northcott · Children's Research Hospital6 papers (2018–2019)Stefan M. Pfister · Université du Québec4 papers (2018–2019)Giles Robinson · Children's Research Hospital4 papers (2018–2019)Amar Gajjar · Mills Peninsula Health Services3 papers (2018–2019)Daniel C. Bowers · Massachusetts General Hospital2 papers (2018–2019)Murali Chintagumpala · Institute of Molecular and Cell Biology2 papers (2018–2019)David Jones · Mayo Clinic in Florida2 papers (2018–2019)Maximilian Deng · Heidelberg University2 papers (2018–2019)Rahul Kumar · Galgotias University2 papers (2018–2019)Brent A. Orr · Research Institute of Radiology2 papers (2018–2019)Sarah Leary · Neurological Surgery2 papers (2018–2019)Girish Dhall · Children's of Alabama2 papers (2018–2019)Robert J. Wechsler‐Reya · Columbia University Irving Medical Center1 papers (2019–2019)Maryam Fouladi · University of Cincinnati1 papers (2019–2019)Éric Bouffet · Université Laval1 papers (2019–2019)Cynthia Hawkins · Université Laval1 papers (2019–2019)Dolores Hambardzumyan · Cancer Institute (WIA)1 papers (2019–2019)Marcel Kool · European Bioinformatics Institute1 papers (2018–2018)William A. Weiss · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2019–2019)Katja von Hoff · Aarhus University1 papers (2018–2018)